* Industry diversification based on Moody's industry classification. Measured as the fair value of investments for each category against the total fair value of all investments. Totals may not sum due to rounding.

A balanced portfolio built on the cornerstones of diversification and selectivity
Anchored in senior secured loans, NCDL has built a scaled and diversified portfolio by industry, investment type and portfolio company. Selectivity, diversification and rigorous underwriting are key to our investment philosophy, enabling strong credit performance since inception.
Portfolio holdings
Top ten positions
Represents the top ten positions in NCDL based on Fair Value as of March 31, 2025
Company | Fair value ($ in thousands) | Industry | Asset Types | Pricing1 |
---|---|---|---|---|
Tinuiti Inc. | 9,599,159 | Media: Advertising, Printing & Publishing | First Lien Debt (Delayed Draw) | S + 5.25% |
Davidson Hotel Company LLC | (9,133) | Hotel, Gaming & Leisure | First Lien Debt (Delayed Draw) | S + 5.00% |
Venture Buyer, LLC (Velosio) | 1,284 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 5.25% |
Solve Industrial Motion Group LLC | 1,801,480 | High Tech Industries | Subordinated Debt | 10.00% (Cash) 2.00% (PIK) |
Solve Group Holdings, L.P. (Solve Industrial) | 153,447 | High Tech Industries | Equity Investment | |
Solve Industrial Motion Group LLC | 785,735 | High Tech Industries | Subordinated Debt | 10.00% (Cash) 2.50% (PIK) |
Solve Industrial Motion Group LLC | 2,063,398 | High Tech Industries | Subordinated Debt (Delayed Draw) | 10.00% (Cash) 2.00% (PIK) |
Venture Buyer, LLC (Velosio) | 6,191,329 | High Tech Industries | First Lien Debt | S + 5.25% |
Diligent Corporation (fka Diamond Merger Sub II, Corp.) | 14,819,032 | High Tech Industries | First Lien Debt | S + 5.00% |
Diligent Corporation (fka Diamond Merger Sub II, Corp.) | 2,540,484 | High Tech Industries | First Lien Debt | S + 5.00% |
SM Wellness Holdings, Inc. (Solis Mammography) | 12,891,154 | Healthcare & Pharmaceuticals | First Lien Debt | S + 4.50% |
Sandlot Buyer, LLC (Prime Time Healthcare) | 9,390,951 | Healthcare & Pharmaceuticals | First Lien Debt | S + 6.25% |
Smile Brands Inc. | 9,390,191 | Healthcare & Pharmaceuticals | Subordinated Debt | S + 8.50% |
TBRS, Inc. | (21,431) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 4.75% |
TBRS, Inc. | 8,002,388 | Healthcare & Pharmaceuticals | First Lien Debt | S + 4.75% |
TBRS, Inc. | 70,742 | Healthcare & Pharmaceuticals | Revolving Loan | S + 4.75% |
Sandlot Buyer, LLC (Prime Time Healthcare) | 7,758,729 | Healthcare & Pharmaceuticals | First Lien Debt | S + 6.25% |
REP HS Holdings, LLC (HemaSource) | 800,299 | Healthcare & Pharmaceuticals | Equity Investment | |
QHR Health, LLC | 3,206,880 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
QHR Health, LLC | 7,581,316 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
QHR Health, LLC | 3,206,880 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
RCP Nats Co-Investment Fund LP | 1,000,000 | Healthcare & Pharmaceuticals | Equity Investment | |
REP Coinvest III AAD, L.P. (Anne Arundel) | - | Healthcare & Pharmaceuticals | Equity Investment | |
Tidi Legacy Products, Inc. | 15,454,246 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
Tidi Legacy Products, Inc. | 33,465 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
YI, LLC (Young Innovations) | (44,828) | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.75% |
YI, LLC (Young Innovations) | 16,132,345 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.75% |
Alta Buyer, LLC (GoEngineer) | 11,347,021 | High Tech Industries | First Lien Debt | S + 5.00% |
Alta Buyer, LLC (GoEngineer) | 3,090,536 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 5.00% |
Diligent Corporation (fka Diamond Merger Sub II, Corp.) | (12,766) | High Tech Industries | First Lien Debt (Delayed Draw) | S + 5.00% |
1. The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at March 31, 2025. As of March 31, 2025, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 4.32%, 4.29%, 4.19%, and 4.01% respectively. Certain investments are subject to a SOFR floor or may utilize an alternative reference rate such as U.S. Prime Rate (“P”). For fixed rate loans, a spread above a reference rate is not applicable.